Mireli W. Fino, MBA

Executive Vice Chancellor

MassBiologics of UMass Chan

In her role as the executive vice chancellor of MassBiologics of UMass Chan, Mireli W. Fino, MBA, will drive MassBiologics mission through the research and development of internal programs with UMass Chan faculty and students while leading the manufacturing facilities in Mattapan and Fall River, and fostering the organization’s industry relationships.

Prior to joining MassBiologics in July of 2021, Fino spent nearly 30 years in the pharmaceutical industry as an accomplished biotech executive with particular expertise in bioprocess development, manufacturing sciences and technology and commercial operations. Most recently, she was with Protein Sciences, in Meriden, Conn., as senior vice president for manufacturing operations since 2012. There, she was instrumental in the approval and launch of the first recombinant influenza vaccine in the U.S. After Sanofi’s 2017 acquisition of Protein Sciences, Fino became the site head of industrial operations, Meriden Conn., and Pearl River New York, where she led the expansion of commercial operations to multiple sites, contract manufacturing organizations and international registrations.

Fino previously worked for 16 years at Wyeth Pharmaceuticals now Pfizer, Inc., in a variety of senior roles, leading large-scale process development and clinical production of viral and bacterial vaccines; ultimately, she was director of manufacturing sciences and technology for bacterial conjugated vaccines, with focus on innovation and new technology implementation. 

Fino earned an undergraduate degree in biochemical engineering at The Autonomous University of Aguascalientes in Mexico and an MBA at MIT.